ESR1 and breast cancer: Consistent with our hypothesis, our data showed significantly increased proliferation in the MCF-7 PARP7KO cells compared to wildtype cells, indicating that endogenous PARP7 negatively affects breast cancer cell proliferation, possibly due to repression of ERα.